Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Anticoagulants are medicinal substances that reduce blood clotting and prolong clotting time. Anticoagulant drugs achieve their effects by inhibiting the synthesis or function of various coagulation factors in the blood.
North America is expected to remain dominant throughout the forecast period. The global anticoagulants market is expected to grow at a compound annual growth rate (CAGR) of 5.6% during the forecast period from 2020 to 2026.
The global anticoagulant market is expected to grow due to the introduction of drugs with lower side effects and higher efficacy, the increasing prevalence of cardiovascular disease worldwide and the increased adoption of new oral anticoagulants (NOACs) in North America and Europe.
The report details the trend, potential and market size of Anticoagulants market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Anticoagulantsmarket, defines the market attractiveness level of Anticoagulants market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Anticoagulants industry, describes the types of Anticoagulants market, the applications of major players and the market size, and deeply analyzes the current situation of the global Anticoagulants market and the development prospects and opportunities of Anticoagulants industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Anticoagulants market in Chapter 13.
By Player:
Pfizer
Lilly
Sanofi
Bristol-Myers Squibb
Boehringer Ingelheim
Daiichi Sankyo
Bayer
Aspen
The Medicines Company
Johnson & Johnson
Otsuka
Genentech (Roche)
AstraZeneca
By Type:
Platelet aggregation inhibitors (PAI)
Low-molecular-weight Heparin (LMWH)
Direct thrombin inhibitor (DTI)
Direct factor Xa inhibitors (DFXa)
Vitamin K antagonists (VKA)
Others
By End-User:
VTE
ACS/MI
AF
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Anticoagulants Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Anticoagulants Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Anticoagulants Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Anticoagulants Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Anticoagulants Market Analysis and Outlook to 2022
-
7.1 Global Anticoagulants Consumption (2017-2022)
-
7.2 United States Anticoagulants Consumption (2017-2022)
-
7.3 Europe Anticoagulants Consumption (2017-2022)
-
7.4 China Anticoagulants Consumption (2017-2022)
-
7.5 Japan Anticoagulants Consumption (2017-2022)
-
7.6 India Anticoagulants Consumption (2017-2022)
-
7.7 South Korea Anticoagulants Consumption (2017-2022)
8 Region and Country-wise Anticoagulants Market Analysis and Outlook to 2028
-
8.1 Global Anticoagulants Consumption Forecast (2022-2028)
-
8.2 United States Anticoagulants Consumption Forecast (2022-2028)
-
8.3 Europe Anticoagulants Consumption Forecast (2022-2028)
-
8.4 China Anticoagulants Consumption Forecast (2022-2028)
-
8.5 Japan Anticoagulants Consumption Forecast (2022-2028)
-
8.6 India Anticoagulants Consumption Forecast (2022-2028)
-
8.7 South Korea Anticoagulants Consumption Forecast (2022-2028)
9 Global Anticoagulants Market Outlook by Types and Applications to 2022
-
9.1 Global Anticoagulants Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Platelet aggregation inhibitors (PAI) Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Low-molecular-weight Heparin (LMWH) Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Direct thrombin inhibitor (DTI) Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Direct factor Xa inhibitors (DFXa) Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Vitamin K antagonists (VKA) Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Anticoagulants Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global VTE Consumption and Growth Rate (2017-2022)
-
9.2.2 Global ACS/MI Consumption and Growth Rate (2017-2022)
-
9.2.3 Global AF Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Anticoagulants Market Outlook by Types and Applications to 2028
-
10.1 Global Anticoagulants Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Platelet aggregation inhibitors (PAI) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Low-molecular-weight Heparin (LMWH) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Direct thrombin inhibitor (DTI) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Direct factor Xa inhibitors (DFXa) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Vitamin K antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Anticoagulants Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global VTE Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global ACS/MI Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global AF Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Anticoagulants Import and Export Analysis (Top 5 Countries)
-
11.1 Global Anticoagulants Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Anticoagulants Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Anticoagulants Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Anticoagulants Market Competitive Analysis
-
14.1 Pfizer
-
14.1.1 Pfizer Company Details
-
14.1.2 Pfizer Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Pfizer Anticoagulants Product and Service
-
14.2 Lilly
-
14.2.1 Lilly Company Details
-
14.2.2 Lilly Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Lilly Anticoagulants Product and Service
-
14.3 Sanofi
-
14.3.1 Sanofi Company Details
-
14.3.2 Sanofi Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Sanofi Anticoagulants Product and Service
-
14.4 Bristol-Myers Squibb
-
14.4.1 Bristol-Myers Squibb Company Details
-
14.4.2 Bristol-Myers Squibb Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Bristol-Myers Squibb Anticoagulants Product and Service
-
14.5 Boehringer Ingelheim
-
14.5.1 Boehringer Ingelheim Company Details
-
14.5.2 Boehringer Ingelheim Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Boehringer Ingelheim Anticoagulants Product and Service
-
14.6 Daiichi Sankyo
-
14.6.1 Daiichi Sankyo Company Details
-
14.6.2 Daiichi Sankyo Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Daiichi Sankyo Anticoagulants Product and Service
-
14.7 Bayer
-
14.7.1 Bayer Company Details
-
14.7.2 Bayer Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Bayer Anticoagulants Product and Service
-
14.8 Aspen
-
14.8.1 Aspen Company Details
-
14.8.2 Aspen Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Aspen Anticoagulants Product and Service
-
14.9 The Medicines Company
-
14.9.1 The Medicines Company Company Details
-
14.9.2 The Medicines Company Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 The Medicines Company Anticoagulants Product and Service
-
14.10 Johnson & Johnson
-
14.10.1 Johnson & Johnson Company Details
-
14.10.2 Johnson & Johnson Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Johnson & Johnson Anticoagulants Product and Service
-
14.11 Otsuka
-
14.11.1 Otsuka Company Details
-
14.11.2 Otsuka Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Otsuka Anticoagulants Product and Service
-
14.12 Genentech (Roche)
-
14.12.1 Genentech (Roche) Company Details
-
14.12.2 Genentech (Roche) Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Genentech (Roche) Anticoagulants Product and Service
-
14.13 AstraZeneca
-
14.13.1 AstraZeneca Company Details
-
14.13.2 AstraZeneca Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 AstraZeneca Anticoagulants Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Anticoagulants
-
Figure Anticoagulants Picture
-
Table Global Anticoagulants Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anticoagulants Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anticoagulants Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Anticoagulants Consumption by Country (2017-2022)
-
Figure United States Anticoagulants Consumption and Growth Rate (2017-2022)
-
Table Europe Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure China Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Japan Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure India Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure South Korea Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Global Anticoagulants Consumption Forecast by Country (2022-2028)
-
Figure United States Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Platelet aggregation inhibitors (PAI) Consumption and Growth Rate (2017-2022)
-
Figure Global Low-molecular-weight Heparin (LMWH) Consumption and Growth Rate (2017-2022)
-
Figure Global Direct thrombin inhibitor (DTI) Consumption and Growth Rate (2017-2022)
-
Figure Global Direct factor Xa inhibitors (DFXa) Consumption and Growth Rate (2017-2022)
-
Figure Global Vitamin K antagonists (VKA) Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global VTE Consumption and Growth Rate (2017-2022)
-
Figure Global ACS/MI Consumption and Growth Rate (2017-2022)
-
Figure Global AF Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Platelet aggregation inhibitors (PAI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Low-molecular-weight Heparin (LMWH) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Direct thrombin inhibitor (DTI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Direct factor Xa inhibitors (DFXa) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vitamin K antagonists (VKA) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global VTE Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ACS/MI Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global AF Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Anticoagulants Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Anticoagulants Export by Region (Top 5 Countries) (2017-2028)
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Anticoagulants Product and Service
-
Table Lilly (Foundation Year, Company Profile and etc.)
-
Table Lilly Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lilly Anticoagulants Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Anticoagulants Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Anticoagulants Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Anticoagulants Product and Service
-
Table Daiichi Sankyo (Foundation Year, Company Profile and etc.)
-
Table Daiichi Sankyo Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi Sankyo Anticoagulants Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Anticoagulants Product and Service
-
Table Aspen (Foundation Year, Company Profile and etc.)
-
Table Aspen Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aspen Anticoagulants Product and Service
-
Table The Medicines Company (Foundation Year, Company Profile and etc.)
-
Table The Medicines Company Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
Table The Medicines Company Anticoagulants Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Anticoagulants Product and Service
-
Table Otsuka (Foundation Year, Company Profile and etc.)
-
Table Otsuka Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Otsuka Anticoagulants Product and Service
-
Table Genentech (Roche) (Foundation Year, Company Profile and etc.)
-
Table Genentech (Roche) Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genentech (Roche) Anticoagulants Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Anticoagulants Product and Service
-
